Skip to main content
Caplight Logo









1cBio, Inc.

1cBio, Inc.

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.1cbio.com/

Company Overview

1cBio, Inc. is a biotechnology company that develops precision medicines for cancer and rare diseases using expertise in medicinal chemistry and translational sciences.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

small molecule therapeuticsdrug discoveryprecision medicinebiotechoncologyrare metabolic diseasesmedicinal chemistrytranslational sciencePARP1 inhibitorDNA damage responseDDRdrug licensingbiopharmahypophosphatasiadrug pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

1cBio, Inc. Comparables

Compare 1cBio, Inc. with similar companies based on industry and business-model similarity.

1cBio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Duke Street Bio
86%
Acerand Therapeutics
82%
Synnovation Therapeutics
81%

1cBio, Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 447% MoM, from 331 to 1.8K.

  • Feb 22, 2025

    Monthly visitors increased 31% MoM, reaching 1.3K.

1cBio, Inc. Filings

Explore SEC and related filing metadata, where available.

1cBio, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 1cBio, Inc.'s valuation, stock price, and market status.

Is 1cBio, Inc. a public or private company?

1cBio, Inc. is a private company.

What is the current stock price of 1cBio, Inc.?

1cBio, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is 1cBio, Inc. worth (valuation)?

Valuation information for 1cBio, Inc. is not publicly available.

Can I buy 1cBio, Inc. stock?

1cBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 1cBio, Inc.'s last funding round?

Funding round information for 1cBio, Inc. is not publicly available.

Who are the main investors in 1cBio, Inc.?

Investor information for 1cBio, Inc. is not publicly disclosed.

Will 1cBio, Inc. IPO soon?

No public IPO plans have been announced for 1cBio, Inc..

How can I track 1cBio, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 1cBio, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range3
Year Founded2022
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?